Aneurysm clinical trials
The registry lists 381 studies for Aneurysm across more than 10 countries. 78 are recruiting or about to start. 117 of them are mainly about Aneurysm (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 13 narrower conditions too, such as Aortic Aneurysm, Abdominal: 1,677 studies, 431 open.
Get an email when these change. Save the Aneurysm studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
TriVascular, Inc. (9) · JOTEC GmbH (9) · National Heart, Lung, and Blood Institute (NHLBI) (7) · W.L.Gore & Associates (7) · Centre hospitalier de l'Université de Montréal (CHUM) (7) · Vascutek Ltd. (6) · University of Missouri-Columbia (6) · Phenox GmbH (6)
What is being tested here
Drugs under test in Aneurysm studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Propranolol | 3 | 0 | 4 |
| Norepinephrine | 2 | 0 | 3 |
| Phentolamine | 2 | 0 | 3 |
| Isoproterenol | 2 | 0 | 2 |
| Phenylephrine | 1 | 0 | 2 |
| Angiotensin II | 1 | 0 | 2 |
| Vibegron | 1 | 0 | 1 |
| Infliximab | 1 | 0 | 1 |
| Lidocaine | 1 | 0 | 1 |
| Tadalafil | 1 | 0 | 1 |
Drug classes tested here Beta blockers 3 open · PDE5 inhibitors 1 open · Inhaled anesthetics 3
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest
- Nov 2026Multimodal Approach Feasability Study for Untreated and Unruptured Intracranial Aneurysms · Resolve Stroke
- Nov 2026Intranasal Sphenopalatine Ganglion Blockade for Headaches Following Aneurysmal Subarachnoid Hemorrhage · Wright State University
- Nov 2026Vasodilator and Exercise Study for DMD (VASO-REx) · University of Florida
- Nov 2026Thoracoabdominal Aortic Stent System for Endovascular Treatment of Thoracoabdominal Aortic Dissecting Aneurysm. · Lifetech Scientific (Shenzhen) Co., Ltd.
- Dec 2026Impact of Early Aging and Menopause on the Vascular Responses to Hypoxia · University of Missouri-Columbia
- Dec 2026LUMENS-1 EU EFS CIP · LuSeed Vascular LTD.
- Dec 2026First In Human Study for Small to Medium-sized Abdominal Aortic Aneurysm (AAA) · Nectero Medical, Inc.
- Dec 2026Reducing Blood Pressure in Mid-life Adult Binge Drinkers · The University of Texas at Arlington
- Dec 2026Determining Postoperative Recovery and the Impact of Adverse Events in Neurosurgery Based on Self-reported, App-based Longitudinal Assessment · Cantonal Hospital of St. Gallen
- Dec 2026SEAL™ME: Saccular Endovascular Aneurysm Lattice System Multicenter Enrollment Global Registry · Galaxy Therapeutics INC
Who these studies take
Of the 67 Aneurysm studies recruiting now, 42 (63%) set no upper age limit and 7 (10%) stop at 75 or younger. 6 (9%) take children under 18. 1 (1%) are for women only and 2 (3%) for men only; 9 (13%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 5 (7%) | 6 (9%) |
| 18 | 61 (91%) | 62 (93%) |
| 30 | 63 (94%) | 64 (96%) |
| 40 | 63 (94%) | 64 (96%) |
| 50 | 61 (91%) | 62 (93%) |
| 65 | 61 (91%) | 62 (93%) |
| 75 | 59 (88%) | 61 (91%) |
| 85 | 49 (73%) | 51 (76%) |
Across all 381 studies, recruiting or not: 17% stop at 75 or younger and 10% at 65; 13% take children; 1% are for women only and 1% for men only; 20% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Aneurysm studies take
Of 83 interventional studies with no phase under Aneurysm, half reached primary completion within 45 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Interventional, no phase | 45 mo19–134 · 83 studies | — | 75 mo12–… · 45 studies |
| Observational | 46 mo33–67 · 69 studies | 42 mo33–61 · 41 studies | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 11, 2026.
Started recruiting2
- Post Approval Study - Evaluate the Long-Term Safety and Effectiveness of the WEB DeviceNov 10, 2026NCT04839705
- Multimodal Approach Feasability Study for Untreated and Unruptured Intracranial AneurysmsOct 13, 2026NCT07864389
Stopped1
- The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs StudiesSuspendedOct 29, 2026NCT06454344
Studies
Recruiting first, then most recently updated. Showing 50 of 381. Browse all 381 → or search them.
- Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic AneurysmRecruitingNCT00483249Not applicable1 country
- Post Approval Study - Evaluate the Long-Term Safety and Effectiveness of the WEB DeviceRecruitingNCT04839705Not applicable1 country
- Treatment in Thoracic Aortic Aneurysm: Surgery vs SurveillanceRecruitingNCT03536312Not applicable3 countries
- Endovascular Treatment of Thoracic Aortic DiseaseEnrolling by invitationNCT00583817Not applicable1 country
- Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)RecruitingNCT06872684Not applicable1 country
- Multimodal Approach Feasability Study for Untreated and Unruptured Intracranial AneurysmsRecruitingNCT07864389Not applicable1 country
- The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial AneurysmsRecruitingNCT07143019Not applicable1 country
- A Closed Loop Neural Activity Triggered Stroke Rehabilitation DeviceRecruitingNCT02098265Not applicable1 country
- Impact of Early Aging and Menopause on the Vascular Responses to HypoxiaRecruitingNCT06417177Early Phase 11 country
- Multimodal Biocollection Linked to the French Register of Intracranial AneurysmsRecruitingNCT06689410Not applicable1 country
- CAAAs, TAAAs, Aortic Arch Aneurysms or Dissections With Fenestrated/Branched Stent GraftRecruitingNCT02089607Not applicable1 country
- PANTHER Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular PatchesRecruitingNCT045455026 countries
- Progression, Management, and Clinical Outcomes of Coronary Artery AneurysmsRecruitingNCT077640811 country
- PMCF Registry to Describe the Safety and Performance of p64, p48 MW and p64 MW in FranceRecruitingNCT077485721 country
- A Standard Carbon Dioxide Flushing Protocol to Reduce Air Embolization During Thoracic Endovascular Aortic RepairRecruitingNCT07734584Not applicable1 country
- Sex Disparities in Hypoxic Vasodilation and Impact of ObesityRecruitingNCT05219799Early Phase 11 country
- A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the AortaRecruitingNCT07078383Not applicable5 countries
- Individual Patient Data Meta-Analysis of Prospective Studies of Patients Treated With the GORE® Iliac Branched EndoprosthesisRecruitingNCT077046711 country
- Cera™ Vascular Plug System Post-Market Clinical Follow-UpRecruitingNCT060990153 countries
- Infliximab Therapy for Dolichoectactic Vertebrobasilar AneurysmsRecruitingNCT02638701Phase 1/21 country
- GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis Post-Market Clinical Follow-Up (PMCF) Observational Registry (RE-PROVE)RecruitingNCT072796491 country
- Reducing Blood Pressure in Mid-life Adult Binge DrinkersRecruitingNCT05522075Not applicable1 country
- Intranasal Sphenopalatine Ganglion Blockade for Headaches Following Aneurysmal Subarachnoid HemorrhageRecruitingNCT07116408Phase 41 country
- Nectero EAST System Retreatment StudyRecruitingNCT07505082Not applicable2 countries
- Vasodilator and Exercise Study for DMD (VASO-REx)RecruitingNCT06290713Phase 21 country
- Safety, Feasibility, and Efficacy of Non-invasive Vagus Nerve Stimulation (nVNS) in the Treatment of Aneurysmal Subarachnoid HemorrhageRecruitingNCT05103566Not applicable1 country
- Red Light Treatment in Peripheral Artery DiseaseRecruitingNCT03203239Not applicable1 country
- Prospective Aortic Biobank of POP-STAREnrolling by invitationNCT042694471 country
- Contour Neurovascular System™ ContiNued Access Investigational Device EXempTion (IDE) Trial (NEXT Trial)RecruitingNCT06693011Not applicable1 country
- Lymphatic Injury Visualization in Vascular SurgeryNot yet recruitingNCT07499206Not applicable1 country
- Neurosurgical Outcome NetworkRecruitingNCT067240291 country
- This Three-year Observational Study Involves Patients of All Ages Undergoing Endovascular Treatment for Various Cerebral or Spinal Vascular Conditions. It Aims to Assess Pre- and Post-operative Clinical Conditions, Report Complications, and Identify Preoperative Indicators of Treatment Outcomes. PatRecruitingNCT068057211 country
- EUS-guided Embolization of the Visceral Artery AneurysmNot yet recruitingNCT07490678Not applicable1 country
- Determining Postoperative Recovery and the Impact of Adverse Events in Neurosurgery Based on Self-reported, App-based Longitudinal AssessmentRecruitingNCT063527101 country
- Targeting Real World Usage In Stroke TreatmentRecruitingNCT074749355 countries
- PC400 Coils for Treatment of Intracranial AneurysmsNot yet recruitingNCT074648471 country
- Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm (SHIELD)RecruitingNCT06793059Not applicable1 country
- Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch EndoprosthesisRecruitingNCT0621887512 countries
- Multicenter Study to Evaluate the Effectiveness and Safety of Flow-Diverting Stents for Distal Intracranial AneurysmsRecruitingNCT073765901 country
- Flow-diverting Devices for the Treatment of Middle Cerebral Artery Bifurcation AneurysmsNot yet recruitingNCT07372612Phase 4
- Standardized Long Term Follow-up of Patients After Endovascular Embolization of a Brain AneurysmRecruitingNCT028789671 country
- Sympathetic Neurovascular Transduction: Role of Adrenergic Receptors and Sex DifferencesRecruitingNCT05997732Phase 41 country
- Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic PathologiesRecruitingNCT02043691Not applicable1 country
- Placental Learning Model for Neurovascular Microsurgery for the Management of Intracranial AneurysmsRecruitingNCT061175271 country
- ANG-First Trial (Angiotensin II as First-Line Vasopressor Therapy in Cardiac Surgery)RecruitingNCT06487585Phase 41 country
- Effects of Lentil Protein Hydrolysate on Blood Pressure Control, Vascular Function and Exercise PerformanceRecruitingNCT06894875Not applicable1 country
- Endovascular Treatment of TAAA and Aortic Arch Aneurysms Using Fenestrated and Branched Stent GraftsRecruitingNCT02323581Not applicable1 country
- LUMENS-1 Canada Early Feasibility Study Clinical Investigation PlanNot yet recruitingNCT07259018Not applicable1 country
- LUMENS-1 EU EFS CIPRecruitingNCT06761365Not applicable4 countries
- Testosterone Deficiency and Endothelial Dysfunction After Spinal Cord InjuryRecruitingNCT072277401 country